Aripiprazole for the management of olanzapine-induced weight gain

Pharmacopsychiatry. 2009 Jul;42(4):166-7. doi: 10.1055/s-0029-1202262. Epub 2009 Jul 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Aripiprazole
  • Benzodiazepines / adverse effects*
  • Body Weight / drug effects
  • Central Nervous System Agents / therapeutic use*
  • Cholesterol / metabolism
  • Drug Therapy, Combination
  • Female
  • Glucose / metabolism
  • Humans
  • Male
  • Olanzapine
  • Piperazines / therapeutic use*
  • Psychiatric Status Rating Scales
  • Quinolones / therapeutic use*
  • Schizophrenia / drug therapy
  • Treatment Outcome
  • Triglycerides / metabolism
  • Weight Gain / drug effects*

Substances

  • Antipsychotic Agents
  • Central Nervous System Agents
  • Piperazines
  • Quinolones
  • Triglycerides
  • Benzodiazepines
  • Aripiprazole
  • Cholesterol
  • Glucose
  • Olanzapine